Martin Pule | Senior Vice President, Founder, Chief Scientific Officer, Autolus and Clinical Senior Lecturer
University College London

Martin Pule, Senior Vice President, Founder, Chief Scientific Officer, Autolus and Clinical Senior Lecturer, University College London

Martin Pule is Clinical Senior Lecturer in the Dept. of Haematology at UCL Cancer Institute and Honorary Consultant in Haematology at University College London Hospital. His research is focused on many aspects of genetic engineering of T-cells for cancer treatment, with a particular focus on CARs. He entered the T-cell engineering field in 2001 as a travelling Fulbright Scholar at the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston. Here, Martin Pule was the first to describe third generation forms of CARs and described one of the first clinical studies of CARs, which showed efficacy in a solid cancer. Martin Pule is Director of the UCL Chimeric Antigen Receptor (CAR) programme. He holds a Bachelor of Medicine and Bachelor of Surgery from University College Dublin and is a Fellow of the Royal College of Pathologists.

Appearances:



Conference Day 1 - Tuesday 31st March 2020 @ 09:20

Realizing the promise of ATMPs for patients around the world

  • Working with regulators to navigate scale up challenges in manufacturing
  • Strategies in supply chain and patient delivery
  • Tackling post manufacturing commercialization challenges such as pricing and finding highly skilled experts
  • Durability

Conference Day 1 - Tuesday 31st March 2020 @ 11:20

Keynote presentation: War in the Blood - the latest in the front line of CAR-T clinical research

last published: 03/Aug/20 09:25 GMT

back to speakers